Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania

Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania

Factors contributing to low use of HU among SCD patients exist in high-income countries. The latter leaves a drift of literature on factors for low utilization of HU in developing countries. This study aimed to explore the factors influencing the use of HU in the management of SCD in Tanzania. A qua...

Full description

Bibliographic Details
Main Authors: Manase Kilonzi, Hamu J. Mlyuka, Fatuma Felix Felician, Dorkasi L. Mwakawanga, Lulu Chirande, David T. Myemba, Godfrey Sambayi, Ritah F. Mutagonda, Wigilya P. Mikomangwa, Joyce Ndunguru, Agnes Jonathan, Paschal Ruggajo, Irene Kida Minja, Emmanuel Balandya, Julie Makani, Nathanael Sirili
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Hemato
Subjects:
hydroxyurea
barriers
facilitators
utilization
Online Access:https://www.mdpi.com/2673-6357/2/4/48

Similar Items

Similar Items